Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Chae-young Lee, Medical Doctor
Anyang Sam Medical Center
Principal Investigator - Jae-yong Park, Professor
Kyungpook University Hospital
Principal Investigator - Seung-beom Han, Professor
Keimyung University Dongsan Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Keimyung University Dongsan Hospital
Daegu, Jung-gu, South Korea
Completed - Kyungpook University Hospital
Deagu, Jung-gu, South Korea
Completed - Sam Anyang Medical Center
Anyang, Man-an-gu, South Korea
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2003
- Primary completion
- 31 May 2011
- Completion
- 30 Jun 2011
- Last update posted
- 1 Mar 2011
- Registered enrollment
- 20
- Registry id
- NCT01305967
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.